Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Cancer Research
|
July 31, 2010
MET receptor sequence variants R970C and T992I lack transforming capacity
Jeffrey W Tyner, Luke B Fletcher, Ellen Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2013
Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer
Christine M Barnett, Michael C Heinrich, Jeong Lim, et al.
Human Pathology
|
June 5, 2012
Multiplex high-throughput gene mutation analysis in acute myeloid leukemia
Jennifer Dunlap, Carol Beadling, Andrea Warrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
KIT gene mutations and copy number in melanoma subtypes
Carol Beadling, Erick Jacobson-Dunlop, F Stephen Hodi, et al.
Cold Spring Harbor Molecular Case Studies
|
August 25, 2021
Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusion
Clare Keddy, Tanaya Neff, Jianya Huan, et al.
Clinical Sarcoma Research
|
March 15, 2019
Genomic aberrations in cell cycle genes predict progression of <i>KIT</i>-mutant gastrointestinal stromal tumors (GISTs)
Michael C Heinrich, Janice Patterson, Carol Beadling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 14, 2021
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma
Alyssa J Penning, Alyaa Al-Ibraheemi, Michael Michal, et al.
The Journal of Molecular Diagnostics : JMD
|
July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry
Carol Beadling, Michael C Heinrich, Andrea Warrick, et al.
NPJ Precision Oncology
|
March 27, 2021
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
Allen Li, Jamie M Keck, Swapnil Parmar, et al.
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Cancer Research
|
July 31, 2010
MET receptor sequence variants R970C and T992I lack transforming capacity
Jeffrey W Tyner, Luke B Fletcher, Ellen Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2013
Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer
Christine M Barnett, Michael C Heinrich, Jeong Lim, et al.
Human Pathology
|
June 5, 2012
Multiplex high-throughput gene mutation analysis in acute myeloid leukemia
Jennifer Dunlap, Carol Beadling, Andrea Warrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
KIT gene mutations and copy number in melanoma subtypes
Carol Beadling, Erick Jacobson-Dunlop, F Stephen Hodi, et al.
Cold Spring Harbor Molecular Case Studies
|
August 25, 2021
Mechanisms of targeted therapy resistance in a pediatric glioma driven by <i>ETV6-NTRK3</i> fusion
Clare Keddy, Tanaya Neff, Jianya Huan, et al.
Clinical Sarcoma Research
|
March 15, 2019
Genomic aberrations in cell cycle genes predict progression of <i>KIT</i>-mutant gastrointestinal stromal tumors (GISTs)
Michael C Heinrich, Janice Patterson, Carol Beadling, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 14, 2021
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma
Alyssa J Penning, Alyaa Al-Ibraheemi, Michael Michal, et al.
The Journal of Molecular Diagnostics : JMD
|
July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry
Carol Beadling, Michael C Heinrich, Andrea Warrick, et al.
NPJ Precision Oncology
|
March 27, 2021
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
Allen Li, Jamie M Keck, Swapnil Parmar, et al.
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
Page
of 5